BridgeMD
New treatment option for Hallux Valgus
Official title Pilot Study of Percutaneous Correction of Hallux Valgus
ClinicalTrials.gov ID: NCT05880407
What this study is testing
- What it's testing
- This is a pilot study with a randomized controlled design.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment
- HVA (hallux valgus angle): 20°-40°
- IMA (intermetatarsal angle): 10°-20°
You likely can't join if
- Patients with instability of the first metatarsophalangeal joint
- Patients with severe morphostructural alterations or other pathologies in the foot and lower limb
- patients requiring additional surgical procedures
- patients with severe vascular and neurological systemic pathologies
- systemic pathologies that may impair bone consolidation
The study team makes the final eligibility decision.
Where it's taking place
- Bologna, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bologna, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.